by Barry Teater, NCBiotech Writer — November 18, 2022 .
RESEARCH TRIANGLE PARK – The nonprofit Regenerative Medicine Development Organization (ReMDO) successful Winston-Salem and Cary-based analytics company SAS are joining forces to amended precocious manufacturing for regenerative medicine applications.
SAS volition lend its expertise in Internet of Things (IoT) analytics and astute manufacturing to ReMDO’s RegeneratOR Test Bed, a “manufacturing-in-a-box” installation that provides companies with state-of-the-art biomanufacturing equipment, manufacture expertise, talent, and grooming programs to enactment caller prototyping and commercialized merchandise development.
SAS besides brings to the confederation decades of acquisition successful the beingness sciences, providing technologies to assistance companies amended the development, manufacturing and commercialization of aesculapian therapies.
The collaboration is intended to assistance regenerative medicine companies amended merchandise output portion reducing variability, contamination and cost.
“Regenerative medicine has been called the adjacent improvement of aesculapian treatments, and SAS is excited to play a relation successful this innovative and important project,” said Udo Sglavo, vice president of precocious analytics R&D astatine SAS. “SAS’ IoT part and the Advanced Analytics Center of Excellence volition use our related manufacture expertise, proven bundle solutions and information analytics techniques to the RegeneratOR Test Bed to beforehand manufacturing imaginable and assistance execute amended outcomes.”
The Test Bed is provided by ReMDO, a nonprofit instauration dedicated to advancing regenerative medicine nationwide, and the Wake Forest Institute for Regenerative Medicine (WFIRM), the world’s largest regenerative medicine institute.
Joshua Hunsberger, Ph.D., main exertion serviceman of ReMDO, said that SAS’ exertion would beryllium a crippled changer for startup companies.
“Smart manufacturing capabilities volition beryllium disposable for immoderate institution successful our Regenerative Medicine Hub,” helium said, referring to the Triad region’s regenerative medicine ecosystem. “These services volition assistance companies optimize and foretell the champion manufacturing processes that could prevention clip and money.”
Anthony Atala, M.D., manager of WFIRM, said, “We judge the Test Bed, done its collaboration with SAS, has a batch to connection successful presumption of helping these companies beryllium successful, and, astatine the aforesaid time, we tin beforehand the regenerative medicine tract nationally.”
The Test Bed is 1 of 3 focused areas that run done ReMDO’s RegeneratOR initiative, which promotes biomanufacturing scale-up and automation to marque technologies much affordable and velocity up the translation to objective practice.
The different 2 absorption areas are the Innovation Accelerator, which supports innovation from probe to commercialization for regenerative medicine companies of each sizes, and the Workforce Development program, which connects colleges, assemblage programs and method schools with biomanufacturing staff, engineers, and probe leaders to bid biomanufacturing technicians and researchers.
More than 30 companies and organizations are progressive successful RegeneratOR.
“It’s breathtaking to spot world-renowned North Carolina expertise from academia and manufacture collaborating to assistance beforehand companies and pull caller opportunities wrong this increasing regenerative medicine hub,” said Nancy Johnston, enforcement manager of the North Carolina Biotechnology Center’s Piedmont Triad Office. The Center partners with SAS and WFIRM and its associated offshoots, and Atala is simply a subordinate of the NCBiotech Board of DIrectors.
ReMDO, WFIRM and their assorted resources are based successful Winston-Salem’s Innovation Quarter, a downtown territory focused connected research, concern and acquisition successful biomedical science, accusation technology, integer media, objective services and precocious materials.
Regenerative medicine is simply a comparatively caller and rapidly increasing tract of medicine that aims to augment, repair, regenerate oregon regenerate quality oregon carnal organs, tissues, cells, genes and metabolic processes damaged by disease, wounded oregon aging.
The planetary marketplace for regenerative medicine reached $9.8 cardinal successful 2021 and is expected to turn to $37.1 cardinal by 2030, a compound yearly maturation complaint of 15.9%, according to a caller investigation by Emergen Research, a Canadian marketplace probe and consulting institution based successful Surrey, British Columbia.
(C) N.C. Biotech Center